Oncotarget is an international peer-review medical journal that extensively covers research on all matters relating to cancer. It was founded in 2008 and is published by Dove Medical Press.
The journal focuses on the causes of all cancers and identifies potential targets for therapy as well as measures that need to be taken to improve monitoring of cancer patients. Additionally, Oncotarget looks at the impact that management programs have on the patients’ lives; if they adhere to set standards and if these programs bring satisfaction to the patients. It scrutinizes the new and existing cancer therapies to determine if they are administered in a manner that t is acceptable to both the patients and the healthcare practitioners. Read more about Oncotarget at Bioxbio.
Benefits of Publishing Your Paper on Oncotarget
As an author, there are several advantages of publishing your papers on Oncotarget. Here is a look at a few of them:
- The journal is electronic, which means there is a lot of space hence no limit to the number of papers to be published. This means your article can never be rejected due to space constraints. You can, therefore, write as many papers as you wish, regardless of their size.
- Oncotarget is an open journal, meaning anyone around the globe can access your paper for free by downloading it directly from the Dove website. This way, your views get to be heard across all nations without any restrictions.
- After submitting your paper, peer reviews take 4 weeks or less. The Journal has one of the fastest turnaround times compared to the other medical journals which take some months thus frustrating authors. You, therefore get to know the final decision from the editors within one month.
- The journal is a member of Committee on Publication Ethics (COPE), which provides guidelines on Best Practice and code of conduct for editors. This means the review and publication process of your paper is unbiased, transparent and methodical.
Oncotarget is undoubtedly a useful tool in creating awareness on cancer in the world. It has been instrumental in research on various aspects of cancer as well as ensuring the oncology programs are beneficial to the patients.
Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/